InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,156.31
(
0.42%
)
Post# of 40492
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Ubertino

Send PM Follow Ignore
Followers 113
Posts 25553
Boards Moderated 4
Alias Born 02/01/2004

Ubertino

Re: None

Tuesday, 06/09/2015 10:10:04 AM

Tuesday, June 09, 2015 10:10:04 AM

Post# of 40492
Inovio Pharmaceuticals, Inc. Analyst Rating Update

by Aubrey Walstrom on June 8, 2015
Inovio Pharmaceuticals, Inc. (NASDAQ:INO): 2 analysts have rated the shares as a strong buy. The Company shares has received a rating of Buy from 4 Wall Street Analysts. Inovio Pharmaceuticals, Inc. shares have received a Mean Price Target of $21. According to the rating issued from 6 Wall Street Analysts, the High Price Target is seen at $31 while the Lower end of the Price Target is seen at $17. The Median Price Target is calculated at $19.5.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent INO News
More INO News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!